Population Pharmacokinetics of Pemetrexed in Adult Non-Small Cell Lung Cancer in Indian Patients.


Journal

Journal of clinical pharmacology
ISSN: 1552-4604
Titre abrégé: J Clin Pharmacol
Pays: England
ID NLM: 0366372

Informations de publication

Date de publication:
09 2019
Historique:
received: 18 12 2018
accepted: 25 03 2019
pubmed: 12 4 2019
medline: 28 7 2020
entrez: 12 4 2019
Statut: ppublish

Résumé

The objective of the study was to develop a population pharmacokinetic model of pemetrexed and identify factors contributing to variability in exposure in Indian patients. Plasma samples were obtained from a cohort of 85 patients following 500 mg/m

Identifiants

pubmed: 30973978
doi: 10.1002/jcph.1417
doi:

Substances chimiques

Antineoplastic Agents 0
Pemetrexed 04Q9AIZ7NO

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1216-1224

Informations de copyright

© 2019, The American College of Clinical Pharmacology.

Auteurs

Meenakshi Srinivasan (M)

University of North Texas Health Science Center, Fort Worth, TX, USA.

Ayyappa Chaturvedula (A)

University of North Texas Health Science Center, Fort Worth, TX, USA.

Michael J Fossler (MJ)

Trevena Inc, Chesterbrook, PA, USA.

Anand Patil (A)

Tata Memorial Centre, Mumbai, India.

Vikram Gota (V)

Tata Memorial Centre, Mumbai, India.

Kumar Prabhash (K)

Tata Memorial Centre, Mumbai, India.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH